multiple-sclerosis-research.org /1 month ago

CAR-T cell therapy

In this study the people had been treated with anti-CD20 antibodies and they had no cells when treatment was started and they B cells began to recover by 12 weeks and back to norma...

Read source
bioengineer.org /1 month ago

Gamma Delta T Cells Blur the Line Between Innate and Adaptive Immunity

New research in Nature shows that gamma delta T cells rely on their adaptive T cell receptors in real time to mount rapid, innate-like tissue surveillance and anti-tumour responses...

Read source
journals.plos.org /1 month ago

How compartmentalization and proliferation shape the splenic T cell repertoire during an immune response to a complex an...

by Franka Buytenhuijs, Cornelia Tune, Thomas C. Smits, Andrea Schampel, Lisa-Kristin Schierloh, René Pagel, Jürgen Westermann, Johannes Textor The adaptive immune system recognize...

Read source
multiple-sclerosis-research.org /1 month ago

Oh my god…I give up..Anti-B cell therapy works because it is killing T cells and now it could be anti-T cell therapy is...

We know that anti-CD20 depleting inhibits relapsing MS very well. This beyond dispute if we are talking about relapsing MS. The T cellers however tell us it is working because they...

Read source
bioengineer.org /1 month ago

Hidden armies inside glioblastoma: exhausted T cells hint at new immunotherapy routes

Single-cell analysis of 56 glioblastoma tumors reveals that T-cell-rich cases harbor clonally expanded, LAG3-high CD8 T cells that may be tumor-reactive, opening new avenues for im...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.